1974
DOI: 10.1002/1097-0142(197402)33:2<468::aid-cncr2820330223>3.0.co;2-f
|View full text |Cite
|
Sign up to set email alerts
|

Parenchymatous degeneration of the central nervous system in childhood leukemia

Abstract: A 7‐year‐old boy with acute lymphocytic leukemia suffered increasing dementia, seizures, ataxia, and spasticity. The neuropathologic findings appeared unique, and included extensive fibrillary gliosis, with lesser degrees of myelin loss and axonal dystrophy. Similar though less severe findings were observed on re‐examination of CNS tissues from 23 other children who died of leukemia. Subcortical fibrillary gliosis was particularly prominent in 22 of 23 cases, and occurred symmetrically in the subependymal and … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
13
0
3

Year Published

1975
1975
1991
1991

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 93 publications
(18 citation statements)
references
References 21 publications
(4 reference statements)
2
13
0
3
Order By: Relevance
“…The pathogenetic mechanism behind the cerebral lesions remains obscure; a number of factors may be involved such as the CSF concentration of MTX [19]; the nature of the diluent [20,21]; folate deficiency, the combination of MTX treatment with CNS irradiation [9,22] and a particular idiosincrasy to MTX [21]. Our findings indicate that whenever both the i.v.…”
Section: Discussionmentioning
confidence: 78%
See 1 more Smart Citation
“…The pathogenetic mechanism behind the cerebral lesions remains obscure; a number of factors may be involved such as the CSF concentration of MTX [19]; the nature of the diluent [20,21]; folate deficiency, the combination of MTX treatment with CNS irradiation [9,22] and a particular idiosincrasy to MTX [21]. Our findings indicate that whenever both the i.v.…”
Section: Discussionmentioning
confidence: 78%
“…Less frequent is an encephalopathy characterized by confusion, somnolence, ataxia, spasticity and ultimately by brain failure. Some neuropathological reports have underlined that there may be demyelination, foci of micronecrosis with astrocytosis and loss of oligodendroglial cells throughout the white matter [9][10][11].…”
Section: Introductionmentioning
confidence: 99%
“…The syndrome of methotrexate-radiation toxicity was first described in children with treated CNS leukaemia (Kay et al, 1972;Hendin et al, 1974;Rubinstein et al, 1975), but has recently been recorded in those who receive prophylactic irradiation and subsequent parenteral methotrexate in fairly high dosage (Price and Jamieson, 1975;McIntosh et al, 1976). We have not encountered permanent neurological impairment in children receiving prophylactic irradiation, possibly because the Medical Research Council protocols involve neither high-dose parenteral nor long-continued intrathecal methotrexate.…”
mentioning
confidence: 72%
“…(2) the damaging effects of chemotherapy and/or radiotherapy (Kay et al, 1972;Hendin et al, 1974;Rubinstein et al, 1975;Price and Jamieson, 1975;Weiss et al, 1974); (3) haemorrhages due to leukaemia or thrombocytopenia (Pitner and Johnson, 1973); and (4) infection to which these patients are abnormally susceptible (Levine et al, 1972;Simone et al, 1972). In the present case we found no signs of recurrent leukaemia, of radionecrosis, of toxic encephalopathy, or of intracranial haemorrhage, but there was clear evidence of an atypical infection of the brain.…”
Section: Discussionmentioning
confidence: 99%